HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells

(2013) DONG HWAN KIM et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice

(2012) Min Ho Jeong et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells

(2012) HYOUN-JI KIM et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression

(2012) Seung Hun Jeong et al.   MOLECULES AND CELLS

Breast cancer statistics, 2011

(2011) Carol DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits

(2009) Francine Z. Marques et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol

(2008) Zengshuan Ma et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise

(2007) Naghma Khan et al.   ANTIOXIDANTS & REDOX SIGNALING